SCHEMBL1474026

SCHEMBL1474026

Nc1nccc(C=O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474578 0.84 GRM4 (0.42)
SCHEMBL3128568 0.77
SCHEMBL21645064 0.77
SCHEMBL4585500 0.76 CCR1 (0.46)
SCHEMBL6750865 0.74 CCR1 (0.44)
SCHEMBL29956097 0.74 CCR1 (0.44)
SCHEMBL27903107 0.74 GRM4 (0.52)
SCHEMBL1717209 0.73
SCHEMBL6791381 0.73
SCHEMBL2051841 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020188122-A1 Novel compounds SMITHKLINE BEECHAM CORPORATION 2002-12-12 US claimed
EP-1229035-A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties SMITHKLINE BEECHAM CORPORATION (US) 2002-08-07 EP claimed
CN-119432634-A Saccharomyces cerevisiae engineering bacteria for synthesizing beta-carotene and construction method and application thereof 北京化工大学 2025-02-14 CN disclosed
US-20230331770-A1 ARGININE MODIFICATION AND CONJUGATION METHODS Encodia, Inc. (US) 2023-10-19 US disclosed
US-11542256-B2 Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors ANGION BIOMEDICA CORP. (US) 2023-01-03 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20200231576-A1 VINYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS ANGION BIOMEDICA CORP. 2020-07-23 US disclosed
CN-107311981-A Show ketone of 2 aminopyrimidine 6 of active anticancer and antiproliferative activity and the like 德西费拉制药有限责任公司 2017-11-03 CN disclosed
CN-105120864-B 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activity 德西费拉制药有限责任公司 2017-05-17 CN disclosed
CN-105120864-A 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activity DECIPHERA PHARMACEUTICALS LLC 2015-12-02 CN disclosed
CN-102574864-B Fused aminodihydropyrimidinone derivatives EISAI R&D MAN CO LTD 2015-04-29 CN disclosed
US-5593992-A CYTOKINE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1997-01-14 US disclosed
WO-1996040143-A1 IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1996-12-19 WO disclosed
EP-0708768-A4 TRI-SUBSTITUTED IMIDAZOLES HAVING MULTIPLE THERAPEUTIC PROPERTIES SMITHKLINE BEECHAM CORP (US) 1996-08-21 EP disclosed
CN-1129447-A Trisubstituted imidazoles having multiple therapeutic effects SMITHKLINE BEECHAM CORP (US) 1996-08-21 CN disclosed
WO-1996021452-A1 CERTAIN 1,4,5-TRI-SUBSTITUTED IMIDAZOLE COMPOUNDS USEFUL AS CYTOKINE SMITHKLINE BEECHAM CORPORATION (US) 1996-07-18 WO disclosed
WO-1996021654-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1996-07-18 WO disclosed
EP-0708768-A1 TRI-SUBSTITUTED IMIDAZOLES HAVING MULTIPLE THERAPEUTIC PROPERTIES SMITHKLINE BEECHAM CORPORATION (US) 1996-05-01 EP disclosed
WO-1995002591-A1 TRI-SUBSTITUTED IMIDAZOLES HAVING MULTIPLE THERAPEUTIC PROPERTIES SMITHKLINE BEECHAM CORPORATION (US) 1995-01-26 WO disclosed
US-3969520-A 2-Amino-4[2-(1-lower alkyl-5-nitro-2-imidiazolyl)vinyl]pyrimidines for treating protozoal and bacterial infections ISTITUTO CHEMIOTERAPICO ITALIANO S.P.A. (IT) 1976-07-13 US disclosed